FDA Inspection 775234 - Damien Sanderlin, MD - March 29, 2012

FDA Inspection 775234 for Damien Sanderlin, MD on March 29, 2012. Classification: Official Action Indicated (OAI).

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA Inspection 775234 for Damien Sanderlin, MD on March 29, 2012. Classification: Official Action Indicated (OAI).

Violation Codes

21 CFR 812.100

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Damien Sanderlin, MD

Inspection Date

March 29, 2012

Product Type

Biologics

Office

Center for Biologics Evaluation and Research

ID: b6ee764f-53bb-4b09-935f-ca1c0faf0102

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox